|
|
immune effector process
|
GO:0002252 |
321 |
0.357
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.284
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.257
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.252
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.234
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.199
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.190
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.185
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.178
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.175
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.150
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.149
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.148
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.147
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.147
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.144
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.144
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.144
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.134
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.132
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.131
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.130
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.129
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.128
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.128
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.125
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.121
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.121
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.116
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.112
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.111
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.110
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.109
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.109
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.108
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.106
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.105
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.105
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.104
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.103
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.099
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.096
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.095
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.095
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.095
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.094
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.093
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.093
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.092
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.091
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.090
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.088
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.088
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.088
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.088
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.088
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.086
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.086
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.084
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.084
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.083
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.082
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.079
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.079
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.079
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.078
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.077
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.077
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.077
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.076
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.076
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.076
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.076
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.075
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.075
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.074
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.072
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.072
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.071
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.071
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.070
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.070
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.070
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.069
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.069
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.068
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.068
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.068
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.068
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.067
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.066
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.066
|
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.066
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.065
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.064
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.063
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.063
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.062
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.062
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.061
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.061
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.061
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.060
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.060
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.059
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.059
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.059
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.059
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.059
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.058
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.058
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.057
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.057
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.057
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.057
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.056
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.056
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.056
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.056
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.056
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.055
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.055
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.055
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.055
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.055
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.055
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.054
|
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
3 |
0.054
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.054
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.054
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.053
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.053
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.053
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.053
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.052
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.052
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.052
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.052
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.052
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.052
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.051
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.051
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.051
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.050
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.049
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.049
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.049
|
|
|
|
regulation of smooth muscle contraction
|
GO:0006940 |
22 |
0.048
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.047
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.047
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.047
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.047
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.047
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.046
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.046
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.046
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.045
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.045
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.045
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.045
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.045
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.045
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.044
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.044
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.044
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.044
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.044
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.044
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.044
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.044
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.043
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.043
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.043
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.043
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.043
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.042
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.042
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.042
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.042
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.042
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.041
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.041
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.041
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.041
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.040
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.040
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.040
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.039
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.039
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.039
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.039
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.039
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.039
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.038
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.038
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.038
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.038
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.037
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.037
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.037
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.037
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.037
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.036
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.036
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.036
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.036
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.036
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.036
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.036
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.035
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.035
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.035
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.035
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
36 |
0.035
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.035
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.035
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.035
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.035
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.034
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.034
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.034
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.034
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.034
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.034
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.033
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.033
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.033
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.033
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.033
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.033
|
|
|
|
sphingolipid biosynthetic process
|
GO:0030148 |
26 |
0.033
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.033
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.033
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.032
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.032
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.032
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.032
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.032
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.032
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.032
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.031
|
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.031
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.031
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.031
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.031
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.031
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.031
|
|
|
|
early endosome to late endosome transport
|
GO:0045022 |
2 |
0.031
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.031
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.031
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.031
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.030
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.030
|
|
|
|
granulocyte chemotaxis
|
GO:0071621 |
39 |
0.030
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.030
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.030
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.030
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.030
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.030
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.030
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.030
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.030
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.030
|
|
|
|
regulation of systemic arterial blood pressure by circulatory renin angiotensin
|
GO:0001991 |
13 |
0.030
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.029
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.029
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.029
|
|
|
|
positive regulation of phospholipase c activity
|
GO:0010863 |
2 |
0.029
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.029
|
|
|
|
purinergic nucleotide receptor signaling pathway
|
GO:0035590 |
3 |
0.029
|
|
|
|
regulation of systemic arterial blood pressure by renin angiotensin
|
GO:0003081 |
20 |
0.029
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.029
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.029
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.029
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.029
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.029
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.029
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.029
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.028
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.028
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.028
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.028
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.028
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.027
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.027
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.027
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.027
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.027
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.027
|
|
|
|
neutrophil chemotaxis
|
GO:0030593 |
36 |
0.027
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.027
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.027
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.027
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.027
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.027
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.027
|
|
|
|
ceramide biosynthetic process
|
GO:0046513 |
20 |
0.027
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.027
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.027
|
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.026
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.026
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.026
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.026
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.026
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.026
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.026
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.026
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.026
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.026
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.026
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.026
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.026
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.025
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.025
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.025
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.025
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.025
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.025
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.025
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.025
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.025
|
|
|
|
mineralocorticoid biosynthetic process
|
GO:0006705 |
1 |
0.025
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.025
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.025
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.025
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.025
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.025
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.025
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.025
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.024
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.024
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.024
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.024
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.024
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.024
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.024
|
|
|
|
integrin mediated signaling pathway
|
GO:0007229 |
27 |
0.024
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.024
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.023
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.023
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.023
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.023
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.023
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.023
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.023
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.023
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.023
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.023
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.022
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.022
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.022
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.022
|
|
|
|
negative regulation of blood pressure
|
GO:0045776 |
22 |
0.022
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.022
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.022
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.022
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.022
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.022
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.022
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.022
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.022
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.022
|
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.022
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.022
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.022
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.022
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.022
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.022
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.022
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
35 |
0.022
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.022
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.021
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.021
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.021
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.021
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.021
|
|
|
|
bronchiole morphogenesis
|
GO:0060436 |
1 |
0.021
|
|
|
|
regulation of acute inflammatory response
|
GO:0002673 |
27 |
0.021
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.021
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
39 |
0.021
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.021
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.021
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.021
|
|
|
|
negative regulation of muscle contraction
|
GO:0045932 |
12 |
0.021
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.021
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.021
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.021
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.021
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.021
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.021
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.021
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.021
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.021
|
|
|
|
ceramide metabolic process
|
GO:0006672 |
31 |
0.020
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.020
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.020
|
|
|
|
endothelial cell proliferation
|
GO:0001935 |
27 |
0.020
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.020
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.020
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.020
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.020
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.020
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.020
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.020
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.020
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.020
|
|
|
|
t cell mediated cytotoxicity
|
GO:0001913 |
26 |
0.020
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.020
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.020
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.019
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.019
|
|
|
|
g protein coupled receptor internalization
|
GO:0002031 |
3 |
0.019
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.019
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.019
|
|
|
|
negative regulation of systemic arterial blood pressure
|
GO:0003085 |
15 |
0.019
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.019
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.019
|
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.019
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.019
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.019
|
|
|
|
av node cell to bundle of his cell communication
|
GO:0086067 |
2 |
0.019
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.019
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.019
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.019
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.019
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.019
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.019
|
|
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.019
|
|
|
|
positive regulation of endothelial cell proliferation
|
GO:0001938 |
17 |
0.019
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.019
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.019
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.018
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.018
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.018
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.018
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.018
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.018
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.018
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.018
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.018
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.018
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.018
|
|
|
|
acid secretion
|
GO:0046717 |
33 |
0.018
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.018
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.018
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.018
|
|
|
|
salivary gland morphogenesis
|
GO:0007435 |
33 |
0.018
|
|
|
|
neutrophil migration
|
GO:1990266 |
37 |
0.018
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.018
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.018
|
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.018
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.017
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.017
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.017
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.017
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.017
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.017
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.017
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.017
|
|
|
|
regulation of white fat cell proliferation
|
GO:0070350 |
2 |
0.017
|
|
|
|
c21 steroid hormone biosynthetic process
|
GO:0006700 |
3 |
0.017
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.017
|
|
|
|
regulation of glomerular filtration
|
GO:0003093 |
3 |
0.017
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.017
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.017
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.017
|
|
|
|
negative regulation of heart rate
|
GO:0010459 |
4 |
0.017
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.017
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.016
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.016
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.016
|
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.016
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.016
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.016
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.016
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.016
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.016
|
|
|
|
branching involved in salivary gland morphogenesis
|
GO:0060445 |
26 |
0.016
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.016
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.016
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.016
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
60 |
0.016
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.016
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.016
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.016
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.016
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.016
|
|
